#Clinical Trials

Sonomind Funding Fuels €3M Push for Novel Brain Stimulation

\n Paris-based Sonomind , a company at the forefront of non-invasive brain stimulation, has successfully secured €3 million ($3.53M).

Treeline Biosciences Raises $200M, Initiates Clinical Trials

The company also initiated Phase 1 trials for three oncology programs, including a pan-KRAS inhibitor.

Mabylon Raises €31.8M to Advance Allergy Antibody Pipeline

Mabylon, a Swiss biotech, secured €31.8 million in new funding. This investment will advance its lead peanut allergy program and early-stage pipeline. The funding came from existing private investors, including former Roche management and board members.

Comphya Secures €8M Series A for ED Neurostimulation

Comphya Secures €8M Series A for ED Neurostimulation

\n Lausanne-based Comphya SA , a clinical-stage MedTech company, recently closed an oversubscribed Series A financing round, raising €8 million.

CNBC Disruptor 50 on Formation Bio to Redefine Drug Development

Neuralink Secures Massive $650M Series E Funding

Vivodyne Secures $40 Million to Revolutionize Drug Discovery

Veltist Secures €160,000 in Funding for Innovative Surgical Patch

MaxisIT Evolves to Maxis AI, Launches Enterprise-Ready Agentic AI Platform to Transform Clinical Trials in Pharmaceutical and Life Sciences Industry

Zetaris Launches AI Clinical Assistant for Improved Healthcare Outcomes

AI and Spatial Biology Startup Nucleai Secured $14 Million Led by M Ventures

Accenture Ventures Backs QuantHealth, Clinical Trial Simulations

PhaseV Nabs $15 Million Funding for ML Clinical Trial Optimization